Foundational AI Platform

Athena Foundational Model

The foundational AI model powering equitable cancer
diagnostics for the #Remaining84

Built on the world’s most diverse cancer dataset, Athena delivers clinical‑grade
AI that works across all populations, cancer types, and resource settings.

Athena: A New Standard in Cancer AI

Athena is a foundational model built on the most diverse and comprehensive cancer dataset worldwide. Trained on data from all continents, it delivers consistent and fair performance across cancer types and populations.

Medical expertise shaped its development at every step, ensuring real‑world relevance and reliability. Athena marks the beginning of a more inclusive, globally impactful approach to cancer care.

10+
Ethnicities
60+
Countries
3.0M+
Images
60+
Primary Sites
130K+
Cases
200+
Biomarkers
30+
AI Models
15+
Cancer Types

See Athena in Action

Discover how our foundational AI model is transforming cancer diagnostics
across the globe.

Athena Platform Demo
Coming Soon

Join Us in Building the Future

We're actively seeking research partners, healthcare institutions, and technology collaborators
to expand Athena's capabilities. Together, we can ensure that advanced cancer AI reaches
every corner of the globe.

Research Partnerships

Collaborate on cutting-edge research projects and contribute to our growing dataset.

Technology Development

Join our developer community and help build the next generation of cancer AI tools.

Transform Your Impact

Possibilities with Athena

Unlock new opportunities across the entire cancer care continuum with AI that works for
everyone, everywhere.

AI‑Driven Drug Discovery

Transform pharmaceutical R&D with population‑aware AI that reduces trial failures and accelerates time‑to‑market.

Higher Clinical Trial Success

Increase success rates by leveraging AI models that understand population diversity from the ground up.

Stratified Patient Selection

Optimize recruitment with AI that understands genetic, environmental, and demographic factors globally.

Post‑Market Surveillance

Monitor treatment effectiveness across diverse patient groups with real‑world AI analysis.

Let's Build Something Global, Together

Join leading institutions worldwide in leveraging our data-first AI platform for equitable cancer
diagnostics.

Subscribe to Our Monthly Newsletter

Each month, we will send key data updates, stories from the field, and new research on inclusive oncology AI.

We respect your privacy. Unsubscribe at any time.